Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 385154, 8 pages
http://dx.doi.org/10.1155/2015/385154
Research Article

Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE−/− Mice Induced by Hyperlipaemia

1Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 725 South Wanping Road, Shanghai 200032, China
2East China University of Science and Technology, Shanghai 200237, China

Received 21 August 2014; Revised 19 September 2014; Accepted 10 October 2014

Academic Editor: Jian-Li Gao

Copyright © 2015 Hewei Qin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Ren, H. Zhang, Y. Mu, M. Sun, and P. Liu, “Pharmacological effects of Astragaloside IV: a literature review,” Journal of Traditional Chinese Medicine, vol. 33, no. 3, pp. 413–416, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. X.-H. Han, P. Liu, Y.-Y. Zhang, N. Zhang, F.-R. Chen, and J.-F. Cai, “Astragaloside IV regulates expression of ATP-sensitive potassium channel subunits after ischemia-reperfusion in rat ventricular cardiomyocytes,” Journal of Traditional Chinese Medicine, vol. 31, no. 4, pp. 321–326, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. I. Borissoff, H. M. Spronk, and H. T. Cate, “The hemostatic system as a modulator of atherosclerosis,” The New England Journal of Medicine, vol. 364, no. 18, pp. 1746–1760, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. W. Semple, J. E. Italiano Jr., and J. Freedman, “Platelets and the immune continuum,” Nature Reviews Immunology, vol. 11, no. 4, pp. 264–274, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Lievens, A. Zernecke, T. Seijkens et al., “Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis,” Blood, vol. 116, no. 20, pp. 4317–4327, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Abi-Younes, A. Sauty, F. Mach, G. K. Sukhova, P. Libby, and A. D. Luster, “The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques,” Circulation Research, vol. 86, no. 2, pp. 131–138, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Schober, S. Knarren, M. Lietz, E. A. Lin, and C. Weber, “Crucial role of stromal cell–derived factor-1α in neointima formation after vascular injury in apolipoprotein E–deficient mice,” Circulation, vol. 108, no. 20, pp. 2491–2497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Sakihama, T. Masunaga, K. Yamashita et al., “Stromal cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis,” Circulation, vol. 110, no. 18, pp. 2924–2930, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Hatse, K. Princen, G. Bridger, E. de Clercq, and D. Schols, “Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4,” The FEBS Letters, vol. 527, no. 1–3, pp. 255–262, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Yao, J. Heuser-Baker, O. Herlea-Pana et al., “Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering,” Stem Cells, vol. 30, no. 12, pp. 2720–2731, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Zinszner, M. Kuroda, X. Wang et al., “CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum,” Genes & Development, vol. 12, no. 7, pp. 982–995, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Hoffman, D. M. Monroe, and H. R. Roberts, “A rapid method to isolate platelets from human blood by density gradient centrifugation,” The American Journal of Clinical Pathology, vol. 98, no. 5, pp. 531–533, 1992. View at Google Scholar · View at Scopus
  13. L. Torregrossa, R. Giannini, N. Borrelli et al., “CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas,” Modern Pathology, vol. 25, no. 1, pp. 46–55, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. M. Kahler, J. Wechselberger, W. Hilbe et al., “Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury,” Respiratory Research, vol. 8, article 50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Shen, L. Sun, H. Zhang et al., “A ROS-mediated lysosomal-mitochondrial pathway is induced by a novel Amonafide analogue, 7c, in human Hela cervix carcinoma cells,” Cancer Letters, vol. 333, no. 2, pp. 229–238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Steinberg, “Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime,” Nature Medicine, vol. 8, no. 11, pp. 1211–1217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Zhang, G. Hu, S. Li et al., “Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo,” Molecular Medicine Reports, vol. 5, no. 3, pp. 805–811, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Zhang, Q. Liu, L. Lu, X. Zhao, X. Gao, and Y. Wang, “Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1α accumulation via phosphatidylinositol 3-kinase/akt pathway,” Journal of Pharmacology and Experimental Therapeutics, vol. 338, no. 2, pp. 485–491, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Zhang, T. Wu, M. Chen, Y. Zhou, D. Yi, and R. Guo, “The CD40/CD40L system: a new therapeutic target for disease,” Immunology Letters, vol. 153, no. 1-2, pp. 58–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Stellos, P. Seizer, B. Bigalke, K. Daub, T. Geisler, and M. Gawaz, “Platelet aggregates-induced human CD34+ progenitor cell proliferation and differentiation to macrophages and foam cells is mediated by stromal cell derived factor 1 in vitro,” Seminars in Thrombosis and Hemostasis, vol. 36, no. 2, pp. 139–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Werner, S. Kosiol, T. Schiegl et al., “Circulating endothelial progenitor cells and cardiovascular outcomes,” The New England Journal of Medicine, vol. 353, no. 10, pp. 999–1007, 2005. View at Publisher · View at Google Scholar · View at Scopus